<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antithymocyte globulin (ATG) has recently been popularized as an effective treatment in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We treated 8 anemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients (<z:hpo ids='HP_0005505'>refractory anemia</z:hpo> [RA] and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts [<z:e sem="disease" ids="C1318550" disease_type="Neoplastic Process" abbrv="">RAEB-1</z:e>]) with ATG (40 mg/kg/d for 4 days) and <z:chebi fb="0" ids="8382">prednisone</z:chebi> in a phase 2 trial </plain></SENT>
<SENT sid="2" pm="."><plain>The study was stopped early according to a preset termination rule because of lack of efficacy </plain></SENT>
<SENT sid="3" pm="."><plain>There were no salutary responses </plain></SENT>
<SENT sid="4" pm="."><plain>Toxicities included <z:e sem="disease" ids="C0036830" disease_type="Disease or Syndrome" abbrv="">serum sickness</z:e> (in <z:hpo ids='HP_0000001'>all</z:hpo> patients), transient <z:hpo ids='HP_0001875'>neutropenia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0002014'>diarrhea</z:hpo>, <z:hpo ids='HP_0002013'>vomiting</z:hpo>, and <z:hpo ids='HP_0001279'>syncope</z:hpo> with a generalized <z:hpo ids='HP_0001250'>seizure</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>At least 3 patients had the HLA-DR15 (DR2) allele </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that the risk-benefit ratio of ATG in an unselected population of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients may be unfavorable, and more work is needed to define the subset of patients who will respond to ATG before its widespread use can be recommended </plain></SENT>
</text></document>